Drug Profile
ADL 5747
Alternative Names: ADL-5747; PF-04856881; PF-4856881; PF-4856881 AdolorLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Adolor Corporation
- Developer Adolor Corporation; Pfizer
- Class
- Mechanism of Action Opioid delta receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 18 Jun 2010 Efficacy and adverse events data from a phase IIa trial in Inflammatory pain (osteoarthritis of knee) released by (Adolor Corporation)
- 27 Jan 2010 Adolor and Pfizer initiate a phase II trial in Pain due to postherpetic neuralgia in USA
- 30 Oct 2009 Phase-II clinical trials in Pain in USA (PO)